Rick E. Winningham - 20 Feb 2026 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Brett A Grimaud, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 20 Feb 2026
Net transactions value: -$1,474,008
Form type: 4
Filing time: 24 Feb 2026, 19:43:51 UTC
Previous filing: 21 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Winningham Rick E	CHIEF EXECUTIVE OFFICER, Director	C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO	/s/ Brett A Grimaud, Attorney-in-Fact	24 Feb 2026	0001302443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Tax liability	$1,474,008	-74,975	-4.5%	$19.66	1,576,094	20 Feb 2026	Direct	F1
holding	TBPH	Ordinary Shares						23,400	20 Feb 2026	As Custodian
holding	TBPH	Ordinary Shares						92,567	20 Feb 2026	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.